2016
DOI: 10.1071/en15202
|View full text |Cite
|
Sign up to set email alerts
|

Neuropsychiatric pharmaceuticals and illicit drugs in wastewater treatment plants: a review

Abstract: Environmental context. Neuropsychiatric pharmaceuticals and illicit drugs in wastewaters are of increasing environmental concern. We compile the recent literature and evaluate the concentrations and profiles of various drugs and their removal efficiencies in wastewater treatment plants. The sewage epidemiology approach, used in the estimation of drug usage in communities, is discussed, and we make recommendations for future research in this area.Abstract. Neuropsychiatric pharmaceuticals and illicit drugs enco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
18
0
2

Year Published

2016
2016
2018
2018

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 41 publications
(20 citation statements)
references
References 140 publications
(320 reference statements)
0
18
0
2
Order By: Relevance
“…Mechanisms to report hospital admissions and forensic toxicology findings may not be publicly available. Wastewater analysis (WWA) has thus been proposed as a suitable complementary means to provide temporal and spatial trends in NPS use, because it can give information on the identity and amount of drugs being used at any given time …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Mechanisms to report hospital admissions and forensic toxicology findings may not be publicly available. Wastewater analysis (WWA) has thus been proposed as a suitable complementary means to provide temporal and spatial trends in NPS use, because it can give information on the identity and amount of drugs being used at any given time …”
Section: Introductionmentioning
confidence: 99%
“…Wastewater analysis (WWA) has thus been proposed as a suitable complementary means to provide temporal and spatial trends in NPS use, because it can give information on the identity and amount of drugs being used at any given time. 7,8 The ever-changing nature of the NPS market means acquiring standards and developing quantitative analytical methods for compounds which may have a short commercial lifetime is unfeasible.…”
mentioning
confidence: 99%
“…Over the past decade, research determining sources and overall fates of PPCPs through STPs, and their distribution in multiple environmental matrices including biota (Subedi et al, 2012), wastewater (Metcalfe et al, 2010;Radjenovic et al, 2009), surface water (Kolpin et al, 2002), drinking water (Benotti et al, 2009), and sludge (Subedi et al, 2013) were studied in developed countries. However, the frequency and concentration of PPCPs can vary depending on the consumption pattern of drugs and the effectiveness of wastewater treatment strategies (Kolpin et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…PPCPs are capable of exerting toxic effects at relatively low concentrations through specific modes of action, and can affect non-target organisms at different trophic levels (Rehman et al, 2015). Antipsychotics, antidepressants, and antibacterials are the three most toxic classes of pharmaceuticals in the environment (Fent et al, 2006;Asimakopoulos and Kannan, 2016). For instance, at environmentally relevant concentrations, carbamazepine altered the ultrastructural cellular reactions in liver, kidney and gills of Oncorhynchus mykiss (rainbow trout) and Cyprinus carpio (common carp) (Triebskorn et al, 2007); diazepam inhibited polyp regeneration of Hydra vulgaris (Pascoe et al, 2003), and metoprolol and verapamil significantly changed the heartbeat of Daphnia magna (Villegas-Navarro et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…However, important WBE research has also been conducted in other continents such as Asia (Lai et al, ; Khan et al, ; Li et al, ; Kim et al, ), Australia (Irvine et al, ; Prichard et al, ; Lai et al, ; Tscharke et al, , ), North America (Banta‐Green et al, ; Burgard et al, ; Subedi & Kannan, ), and Central and South America (Maldaner et al, ; Devault et al, ; Voloshenko‐Rossin et al, ; Bijlsma et al, ). Furthermore, a recently published review on neuropsychiatric pharmaceuticals and illicit drugs in WWTPs (Asimakopoulos & Kannan, ) is recommended for readers interested.…”
Section: Introductionmentioning
confidence: 99%